Synthomer plc (LON:SYNT - Get Free Report)'s stock price fell 13% during mid-day trading on Tuesday . The company traded as low as GBX 95.19 ($1.30) and last traded at GBX 95.19 ($1.30). 3,059,235 shares were traded during trading, an increase of 308% from the average session volume of 749,834 shares. The stock had previously closed at GBX 109.40 ($1.49).
Analysts Set New Price Targets
Separately, Berenberg Bank lowered shares of Synthomer to a "hold" rating and cut their target price for the stock from GBX 230 ($3.14) to GBX 150 ($2.05) in a research note on Wednesday, March 12th.
View Our Latest Research Report on SYNT
Synthomer Price Performance
The stock's fifty day moving average price is GBX 103.50 and its two-hundred day moving average price is GBX 120.07. The firm has a market capitalization of £158.89 million, a price-to-earnings ratio of -1.94, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27.
Insider Buying and Selling at Synthomer
In other news, insider Janet E. Ashdown acquired 19,920 shares of Synthomer stock in a transaction dated Thursday, July 3rd. The shares were acquired at an average cost of GBX 99 ($1.35) per share, for a total transaction of £19,720.80 ($26,922.59). Insiders own 28.00% of the company's stock.
Synthomer Company Profile
(
Get Free Report)
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Recommended Stories
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.